Stopping GLP-1 Treatment 2 Weeks Before Surgery Reduces Anesthesia Complication Risk

Patients should stop using glucagon-like peptide-1 agonists two weeks prior to a total joint arthroplasty to reduce ...

JULY 2, 2025

Two Studies Find Low Risk for Aspiration in Patients on GLP-1 Agonists

There is little evidence to show an increased risk for aspiration pneumonia in surgical patients taking ...

APRIL 30, 2025

Perioperative Gastric Ultrasound Findings in GLP-1 Receptor Agonist Users

Glucagon-like peptide-1 receptor agonists are FDA-approved medications that mimic the action of a naturally ...

NOVEMBER 20, 2024

GLP-1 Agents May Drive Surgery Volume, Experts Predict

With the rising popularity of glucagon-like peptide-1 agents for treating obesity, many bariatric surgery programs ...

NOVEMBER 7, 2024

GLP-1 RAs and Perioperative Risks: Does the Absence of Evidence Indicate Evidence of Absence?

Hidden beneath their acclaim are a number of cases of regurgitation and aspiration of stomach contents in patients ...

OCTOBER 1, 2024

Surgery Bests Lifestyle Changes, GLP-1s for Durable Weight Loss

Bariatric surgery far outperforms lifestyle interventions and glucagon-like peptide-1 medications at maintaining ...

SEPTEMBER 24, 2024

Bariatric Surgery More Renoprotective Than Weight-Loss Meds

In patients with obesity who also have type 2 diabetes and chronic kidney disease, surgery is a better ...

SEPTEMBER 16, 2024

Report: GLP-1 Adherence Rates Lower Than Expected

Although more than 90% of patients adhered to GLP-1 agonists through the end of clinical trials, new data suggest ...

MAY 26, 2024